MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.kint.2020.04.047

Медицинская библиотека · Kidney international · 2020

Baclofen has a risk of encephalopathy in older adults receiving dialysis.

Chauvin Kianna J, Blake Peter G, Garg Amit X, Weir Matthew A, Bathini Lavanya, Dixon Stephanie N, McArthur Eric, Sontrop Jessica M, Moist Louise, Kim Richard B, Muanda Flory T

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

At least 23 case reports link the muscle relaxant baclofen to encephalopathy in patients receiving dialysis. To explore this issue, we conducted a study to quantify the risk of encephalopathy from baclofen in patients receiving dialysis. Linked healthcare databases were used to conduct a population-based cohort study of older adults receiving maintenance dialysis in Ontario, Canada (1997-2018) to compare new users of baclofen to non-users. The primary outcome was the 30-day risk of hospitalization with encephalopathy, defined as a main diagnosis of delirium, disorientation, transient alteration of awareness, or transient cerebral ischemic attack. Inverse probability of treatment weighting on the propensity score was used to balance comparison groups on indicators of baseline health. Weighted risk ratios (RR) were obtained using modified Poisson regression and weighted risk differences (RD) using binomial regression. We studied 360 new baclofen users and 6109 non-users (2638 [41%] women; median age 75). The median baclofen dose was 20 mg/day. Hospitalization with encephalopathy occurred in 26 of 360 baclofen users (7.2%) and in under six of 6109 non-users (under 0.1%); weighted risk ratios, 78.3 (95% confidence interval 27.9 to 219.2); weighted risk differences, 7.1% (4.5% to 9.8%). The median time from baclofen dispensing to hospitalization with encephalopathy was three days. Among patients receiving dialysis, approximately one in 14 were hospitalized with encephalopathy shortly after starting baclofen. Thus, baclofen should be avoided in older adults receiving dialysis, and other muscle relaxants considered in its place. Hence, if baclofen must be used, a low dose should be prescribed, and older adults should be carefully monitored for signs of encephalopathy.

Для цитирования: Chauvin Kianna J, Blake Peter G, Garg Amit X, Weir Matthew A, Bathini Lavanya, Dixon Stephanie N, McArthur Eric, Sontrop Jessica M, Moist Louise, Kim Richard B, Muanda Flory T. Baclofen has a risk of encephalopathy in older adults receiving dialysis.. Kidney international. 2020. DOI: 10.1016/j.kint.2020.04.047.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.